New 'See and Treat' combo targets Hard-to-Treat liver cancer

NCT ID NCT06726161

First seen Apr 29, 2026 · Last updated May 09, 2026 · Updated 1 time

Summary

This study tests a pair of drugs: one that lights up cancer cells on scans (RYZ811) and another that delivers radiation directly to those cells (RYZ801). It is for adults with a type of liver cancer (GPC3-positive) that cannot be removed by surgery and has worsened after one prior treatment. The goal is to see if the treatment shrinks tumors better than standard care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Facility

    RECRUITING

    Birmingham, Alabama, 35233, United States

  • Research Facility

    RECRUITING

    Phoenix, Arizona, 85054, United States

  • Research Facility

    RECRUITING

    Tucson, Arizona, 85719, United States

  • Research Facility

    RECRUITING

    Orange, California, 92868, United States

  • Research Facility

    RECRUITING

    Jacksonville, Florida, 32224, United States

  • Research Facility

    RECRUITING

    Lexington, Kentucky, 40536, United States

  • Research Facility

    RECRUITING

    Baltimore, Maryland, 21287, United States

  • Research Facility

    RECRUITING

    Rochester, Minnesota, 55905, United States

  • Research Facility

    RECRUITING

    Omaha, Nebraska, 68130, United States

  • Research Facility

    RECRUITING

    New York, New York, 10065, United States

  • Research Facility

    RECRUITING

    Houston, Texas, 77030, United States

  • Research Facility

    RECRUITING

    Charlottesville, Virginia, 22908, United States

  • Research Facility

    RECRUITING

    Seattle, Washington, 98109, United States

Conditions

Explore the condition pages connected to this study.